Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
NurExone Biologic Inc.
NRXBF
Primary Symbol:
V.NRX
Healthcare
Biotechnology
NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ExoTherapy production platform and products for a global market. It is involved in the development of ExoPTEN, the first ExoTherapy-based product for acute Spinal Cord Injuries (SCI). The Company is developing treatment for the reversal or reduction of paralysis following...
spinal cord injury (SCI) using Exosomes (membrane-bound extracellular vesicles). This technology, subject to conducting clinical trials and receiving Food and Drug Administration (the FDA) approval, can be used in various conditions such as SCI, Brain Trauma Injury (BTI), and potentially other brain and neurological indications.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (TSXV:NRX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
Next
(4)
•••
GoldCanuck28
X
View Profile
View Bullboard History
Post by
GoldCanuck28
on Nov 14, 2024 12:00pm
More exciting news!
https://stockhouse.com/news/press-releases/2024/11/13/nurexone-biologic-secures-ema-orphan-status-for-exopten-in-spinal-cord-injury
(3)
•••
DPSMAN7
X
View Profile
View Bullboard History
Post by
DPSMAN7
on Nov 14, 2024 9:57am
What a great company!
Watching this company very closely I see great things on the Horizon
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(4)
•••
GoldCanuck28
X
View Profile
View Bullboard History
Post by
GoldCanuck28
on Nov 12, 2024 5:11pm
Watching this closely… time to get involved?
Nurexone Biologic just closed their final private placement round! Could this signal strong growth ahead?
(10)
•••
Mathew177
X
View Profile
View Bullboard History
Post by
Mathew177
on Oct 23, 2024 11:19am
NurExone’s Regenerative Medicine Therapies To Be Recognized
NurExone’s Regenerative Medicine Therapies To Be Recognized at Fall Conferences in the USA (TSXV: NRX, OTCQB: NRXBF) https://www.globenewswire.com/en/news-release/2024/10/23/2967488/0/en/NurExone-s
...more
(10)
•••
Mathew177
X
View Profile
View Bullboard History
Post by
Mathew177
on Oct 16, 2024 11:15am
Why NRX Could Be the Next DRUG Success Story
Why NRX Could Be the Next DRUG Success Story (TSXV: NRX, OTCQB: NRXBF) https://10xalerts.com/why-nrx-could-be-the-next-drug-success-story/
(6)
•••
ElliotGH
X
View Profile
View Bullboard History
Post by
ElliotGH
on Oct 03, 2024 12:28pm
Initiating Coverage of Nurexone: Potential Breakthrough
Initiating Coverage of Nurexone: Potential Breakthrough Treatment for Spinal Injuries (TSXV: NRX, OTCQB: NRXBF) https://pdfhost.io/v/NZmyyLO6n_Initiating_Coverage_of_Nurexone_Potential_Breakthrough
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 12, 2024 4:04pm
New Press Release - NurExone Biologic Extends Global Reach with Presentations at Industry-Leading Conferences
TORONTO and HAIFA, Israel, Sept. 12, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a biopharmaceutical company developing exosome-based therapies for the multi-billion dollar regenerative medicinei market, is pleased to...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 06, 2024 4:03pm
New Press Release - NurExone Demonstrates Extended Therapeutic Window of ExoPTEN Post Spinal-Cord Injury in Preclinical Study
TORONTO and HAIFA, Israel, Sept. 06, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”) is pleased to announce compelling new findings that highlight the therapeutic potential of ExoPTEN for patients with spinal cord injuries....
read article.
(10)
•••
Mathew177
X
View Profile
View Bullboard History
Post by
Mathew177
on Sep 05, 2024 12:50pm
A Closer Look at NurExone: Exosome Innovation with Long-Term
A Closer Look at NurExone: Exosome Innovation with Long-Term Potential (TSXV: NRX, OTCQB: NRXBF) https://10xalerts.com/a-closer-look-at-nurexone-exosome-innovation-with-long-term-potential-tsxv-nrx
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 28, 2024 8:34am
New Press Release - NurExone Reports Second Quarter 2024 Financial Results and Provides Corporate Update
TORONTO and HAIFA, Israel, Aug. 28, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company developing regenerative medicine therapies, is pleased to announce its financial and operational...
read article.
(61)
•••
Flintstone60
X
View Profile
View Bullboard History
Post by
Flintstone60
on Aug 24, 2024 5:06am
News
Source: [url=https://ceo.ca/@globenewswire/nurexone-biologic-invited-to-present-groundbreaking][/url] by @GlobeNewswire on 23 Aug 2024, 22:03 NurExone Biologic Invited to Present
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 23, 2024 4:03pm
New Press Release - NurExone Biologic Invited to Present Groundbreaking ExoPTEN Therapy at Prestigious September Conferences
Participation in the events in Boston and New York highlights the Company's prominence in regenerative medicine and exosome technology TORONTO and HAIFA, Israel, Aug. 23, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”) is...
read article.
(61)
•••
Flintstone60
X
View Profile
View Bullboard History
Post by
Flintstone60
on Aug 20, 2024 9:01am
kolaboration incoming ? :
Linkedin: "Building on recent successes in exosome production, the transfer of manufacturing to a GMP partner, and promising results in treating acute spinal cord injuries and repairing
...more
(61)
•••
Flintstone60
X
View Profile
View Bullboard History
Post by
Flintstone60
on Aug 16, 2024 2:30am
News:
by @GlobeNewswire on 15 Aug 2024, 22:03 NurExone Biologic Achieves Key Milestone in Support of Robust Exosome Manufacturing Process source: https://ceo.ca/@globenewswire/nurexone
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 15, 2024 4:03pm
New Press Release - NurExone Biologic Achieves Key Milestone in Support of Robust Exosome Manufacturing Process
Company demonstrates reliable production from multiple biological sources These manufacturing advancements provide NurExone flexibility in optimizing its exosome production method, ensuring consistency while maintaining efficiencyTORONTO and HAIFA, Israel, Aug. 15, 2024 (GLOBE NEWSWIRE...
read article.
Prev
1
2
3
4
5
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden